Up And Down The Ladder… Job Changes
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone? And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Curis hired Ali Fattaey as president and chief operating o...
Source: Pharmalot - February 22, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized AcelRx Ariad Pharmaceuticals BioFocus Chimerix Curis Greenphire Gyros Lundbeck Protein Science Symphony Clinical Research Source Type: blogs
USMLE Questions – Characteristic Disease Findings
The United States Medical Licensing Examination (USMLE) is designed to emphasize knowledge of clinical scenarios and clinical pearls, even on Step I. Listed below are some commonly encountered disease findings and characteristics. Feature Disease 45, X chromosome Turner’s syndrome 5-HIAA increased in urine Carcinoid syndrome Aganglionic rectum Hirschsrpung’s disease Apple-core sign on barium enema Colon cancer Arched back (opisthotonos) Tetanus Argyll-Robertson pupil Syphilis Ash leaf on forehead Tuberous sclerosis Auer rods Acute myelogenous leukemia Austin Flint murmur Aortic r...
Source: Inside Surgery - January 18, 2013 Category: Surgeons Authors: Editor Tags: Surgpedia USMLE diseases findings VMA water hammer pulse Source Type: blogs
ImmunohistochemistryImmunohistochemistry in the differential diagnosis ofclear cell carcinomas from the kidney, liver, and lung Clear cell carcinoma is a common specimen seen by many surgical pathologists. Given an appropriate clinical context (for example, a patient with a large kidney mass), determining the nature and origin of a clear cell carcinoma can be very easy. However, in other situations this can be a challenging task, primarily because of the tremendous degree of overlap in the morphologic appearance of clear cell carcinomas from different primary sites. This month, we discuss the utility of a number ...
Source: Oncopathology - April 2, 2012 Category: Cancer & Oncology Source Type: blogs
Adenocarcinoma of unknown primary
What do you do when your doctors tell you that you have an adenocarcinoma of unknown primary? Did doctors use the new Pathwork Tissue of Origin test or any other more advanced test than the one used in your hospital? Janet replied in email to Gary’s (Small cell carcinoma of the lungs) post: how her […] (Source: Metastatic liver cancer)
Source: Metastatic liver cancer - June 17, 2009 Category: Cancer Authors: Daughter SK Tags: Adenocarcinoma adenocarcinoma of unknown primary Alternative CANCER TREATMENTS Cancer Prevention Health holistic cancer treatment immune system Source Type: blogs
Small cell carcinoma of the lungs
What do you do when your oncologist gives you a small cell lung cancer prognosis of 6 months with chemotherapy and half as long without chemotherapy? Gary wants to know. Please share your experience like we share ours. Small cell lung cancer prognosis and secondary liver cancer As far as I have […] (Source: Metastatic liver cancer)
Source: Metastatic liver cancer - June 15, 2009 Category: Cancer Authors: Daughter SK Tags: Lung Cancer cell lung cancer chemotherapy lung cancer prognosis oncologist small cell carcinoma of the lungs small cell lung cancer small cell lung cancer prognosis Source Type: blogs
Work up of Carcinoma of Unknown Primary (CUP)
It is often important to determine the site of origin of a metastatic carcinoma of unknown primary site, particularly because this may affect the choice of the treatment. Determination of the primary site may take several steps.Clinical features, such as age, sex, and site of metastases may give a first indication.A detailed pathologic examination of the most accessible biopsied tissue specimen is mandatory in CUP cases. Pathologic evaluation typically consists of hematoxylin-and-eosin stains and immunohistochemical tests.Electron microscopy is rarely used currently, although it may beselectively useful when making treatme...
Source: Oncopathology - May 4, 2009 Category: Cancer & Oncology Tags: Work up of Carcinoma of Unknown Primary (CUP) Source Type: blogs